Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2020

May 22, 2020

33625_dirs_2020-05-21_d94db34f-261d-46b3-983a-140651573bc2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2020-02-28

Reporting Person: Myers Byron (EVP, Sales and Marketing)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-28 Restricted Stock Units $ A 4368 Acquired Common Stock (4368) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2: 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.